Tendencia de la incidencia y la mortalidad en melanoma maligno en los últimos 60 años y análisis de los datos del Registro Poblacional (sic.) de Cáncer de Cali
DOI:
https://doi.org/10.29176/2590843X.236Palabras clave:
melanoma, tendencia, incidencia, tasa de mortalidad, prevalenciaResumen
Introducción. El melanoma maligno cutáneo es uno de los cánceres más agresivos que existen y uno de los de mayor crecimiento global en el mundo. La velocidad con que creció su incidencia después de 1950 ha sido tal, que
ha sido considerado por muchos autores como una epidemia que azota a algunos países.
Materiales y métodos. Se hizo una búsqueda en Pubmed utilizando los términos MeSH melanoma [AND] trends; de los artículos resultantes, se utilizaron los trabajos originales, teniendo en cuenta para la discusión la incidencia, prevalencia, mortalidad, factores de riesgo, factores socioeconómicos, área corporal, sexo y edad.
Resultados y conclusiones. La incidencia del melanoma maligno cutáneo ha aumentado en la mayoría de países. El mayor número de casos y la mayor mortalidad continúan presentándose en hombres, así como las lesiones más avanzadas y de peor pronóstico, en etnias minoritarias y en personas con bajo estrato socioeconómico y pobre acceso a servicios de salud. La mortalidad ha aumentado en la población mayor de 65 años. En Cali, según el análisis del registro de cáncer de Cali, se observa que la incidencia y la mortalidad son más elevadas en hombres y mujeres mayores, con un aumento en la proporción de hombres sobre mujeres.
Biografía del autor/a
Catalina Oliveros
Médica, residente de primer año de Dermatología, Universidad Icesi, Cali, Colombia
Juan Carlos Bravo
Médico patólogo, Fundación Valle del Lili, Universidad Icesi, Cali, Colombia
Ángela Zambrano
Médica oncóloga, Fundación Valle del Lili, Universidad Icesi, Cali, Colombia
Magda Cepeda
Médica, candidata a M.Sc. en Epidemiología, Fundación Valle del Lili, Cali, Colombia
Ana Francisca Ramírez
Médica dermatóloga, oncóloga, Fundación Valle del Lili, Universidad Icesi, Cali, Colombia
Referencias bibliográficas
1. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst. 2001;93:678-83.
2. Hall HI, Miller DR, Rogers JD, Bewerse B. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol. 1999;40:35-42.
3. MacKie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann Oncol.2009;20(Suppl.6):1-7.
4. Aceituno-Madera P, Buendía-Eisman A, Arias-Santiago S, Serrano-Ortega S. Changes in the incidence of skin cancer between 1978 and 2002. Actas Dermosifiliogr. 2010;101:39-46.
5. Montella A, Gavin A, Middleton R, Autier P, Boniol M. Cutaneous melanoma mortality starting to change: A study of trends in Northern Ireland. Eur J Cancer. 2009;45:2360-6.
6. Bulliard JL, Cox B. Cutaneous malignant melanoma in New Zealand: Trends by anatomical site, 1969-1993. Int J Epidemiol. 2000;29:416-23.
7. Héry C, Tryggvadóttir L, Sigurdsson T, Olafsdóttir E, Sigurgeirsson B, Jonasson JG, et al. A melanoma epidemic in Iceland: Possible influence of sunbed use. Am J Epidemiol. 2010;172:762-7.
8. Marcos-Gragera R, Vilar-Coromina N, Galceran J, Borràs J, Clèries R, Ribes J, et al. Rising trends in incidence of cutaneous malignant melanoma and their future projections in Catalonia, Spain: Increasing impact or future epidemic? J Eur Acad Dermatol Venereol. 2010;24:1083-8.
9. Registro Poblacional de Cáncer de Cali, Colombia. Melanoma, 1962-2007. Fecha de consulta: 11 de agosto de 2011. Disponible en: rpcc.univalle.edu.co.
10. Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA. 1989;262:2097-100.
11. Brochez L, Naeyaert JM. Understanding the trends in melanoma incidence and mortality: Where do we stand? Eur J Dermatol. 2000;10:71-5.
12. Lasithiotakis KG, Leiter U, Gorkievicz R, Eigentler T, Breuninger H, Metzler G, et al. The incidence and mortality of cutaneous melanoma in Southern Germany: Trends by anatomic site and pathologic characteristics, 1976 to 2003. Cancer. 2006;107:1331-9.
13. de Vries E, Bray FI, Eggermont AM, Coebergh JW; European Network of Cancer Registries. Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics. Eur J Cancer Prev. 2004;13:387-95.
14. Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol. 2009;27:3-9.
15. Metelitsa AI, Dover DC, Smylie M, de Gara CJ, Lauzon GJ. A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002). J Am Acad Dermatol. 2010;62:227-32.
16. Chellini E, Crocetti E, Carli P, Martini A, Giovannetti L. The melanoma epidemic debate: Some evidence for a real phenomenon from Tuscany, Italy. Melanoma Res. 2007;17:129-30.
17. Pellacani G, Lo Scocco G,Vinceti M,Albertini G, Raccagni AA, Baldassari L, et al .Melanoma epidemic across the millennium: Time trends of cutaneous melanoma in Emilia-Romagna (Italy) from 1997 to 2004. J Eur Acad Dermatol Venereol. 2008;22:213-8.
18. Marcoval J, Moreno A, Torras A, Baumann E, Graells J, Gallego MI. Changes in incidence of malignant melanoma in the last 19 years in a tertiary hospital on the Mediterranean coast. Actas Dermosifiliogr. 2008;99:464-8.
19. Cayuela A, Rodríguez-Domínguez S, Lapetra-Peralta J, ConejoMir JS. Has mortality from malignant melanoma stopped rising in Spain? Analysis of trends between 1975 and 2001. Br J Dermatol. 2005;152:997-1000.
20. Valentín SM, Sánchez JL, Figueroa LD, Nazario CM. Epidemiology of melanoma in Puerto Rico, 1987-2002. P R Health Sci J. 2007;26:343-8.
21. Whiteman DC, Bray CA, Siskind V, Green AC, Hole DJ, Mackie RM. Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion? Eur J Cancer Prev. 2008;17:243-50.
22. Coory M, Baade P, Aitken J, Smithers M, McLeod GR, Ring I. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control. 2006;17:21-7.
23. Buettner PG, MacLennan R. Geographical variation of incidence of cutaneous melanoma in Queensland. Aust J Rural Health. 2008;16:269-77.
24. Holterhues C, Vries E, Louwman MW, Koljenovi S, Nijsten T. Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005. J Invest Dermatol. 2010;130:1807-12.
25. Hallberg O. A theory and model to explain the skin melanoma epidemic. Melanoma Res. 2006;16:115-8.
26. Tryggvadóttir L, Gislum M, Hakulinen T, Klint A, Engholm G, Storm HH, et al. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964- 2003 followed up to the end of 2006. Acta Oncol. 2010;49:665-72.
27. Cicarma E, Juzeniene A, Porojnicu AC, Bruland ØS, Moan J. Latitude gradient for melanoma incidence by anatomic site and gender in Norway 1966-2007. J Photochem Photobiol B. 2010;101:174-8.
28. Pérez-Gómez B, Aragonés N, Gustavsson P, Lope V, López-Abente G, Pollán M. Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women. Br J Dermatol. 2008;158:766-72.
29. Stang A, Pukkala E, Sankila R, Söderman B, Hakulinen T. Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases. Int J Cancer. 2006;119:380-4.
30. Newnham A, Møller H. Trends in the incidence of cutaneous malignant melanomas in the south east of England, 1960-1998. J Public Health Med. 2002;24:268-75.
31. Bulliard JL, Cox B, Semenciw R. Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969-93. Cancer Causes Control. 1999;10:407-16.
32. de Vries E, Houterman S, Janssen-Heijnen ML, Nijsten T, van de Schans SA, Eggermont AM, et al. Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands. Ann Oncol. 2007;18:1110-6.
33. Shoo BA, Kashani-Sabet M. Melanoma arising in African-, Asian-, Latino- and Native-American populations. Semin Cutan Med Surg. 2009;28:96-102.
34. Ulmer MJ, Tonita JM, Hull PR. Trends in invasive cutaneous melanoma in Saskatchewan 1970-1999. J Cutan Med Surg. 2003;7:433-42.
35. Downing A, Newton-Bishop JA, Forman D. Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003. Br J Cancer. 2006;95:91-5.
36. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. J Invest Dermatol. 2009;129:1666-74.
37. Levi F, Te VC, Randimbison L, La Vecchia C. Trends in incidence of various morphologies of malignant melanoma in Vaud and Neuchatel, Switzerland. Melanoma Res. 2005;15:73-5.
38. Rouhani P, Hu S, Kirsner RS. Melanoma in Hispanic and black Americans. Cancer Control. 2008;15:248-53.
39. Rouhani P, Pinheiro PS, Sherman R, Arheart K, Fleming LE, Mackinnon J, et al. Increasing rates of melanoma among nonwhites in Florida compared with the United States. Arch Dermatol. 2010;146:741-6.
40. Hu S, Parmet Y, Allen G, Parker DF, Ma F, Rouhani P, Kirsner RS. Disparity in melanoma: A trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida. Arch Dermatol. 2009;145:1369-74.
41. Bellows CF, Belafsky P, Fortgang IS, Beech DJ. Melanoma in African-Americans: Trends in biological behavior and clinical characteristics over two decades. J Surg Oncol. 2001;78:10-6.
42. Bradford PT, Anderson WF, Purdue MP, Goldstein AM, Tucker MA. Rising melanoma incidence rates of the trunk among younger women in the United States. Cancer Epidemiol Biomarkers Prev. 2010;19:2401-6.
43. Dal H, Boldemann C, Lindelöf B. Does relative melanoma distribution by body site 1960-2004 reflect changes in intermittent exposure and intentional tanning in the Swedish population? Eur J Dermatol. 2007;17:428-34.
44. Nieto A, Ruiz-Ramos M, Abdel-Kader L, Conde M, Camacho F. Gender differences in rising trends in cutaneous malignant melanoma in Spain, 1975-98. Br J Dermatol. 2003;148:110-6.
45. Karlsson PM, Fredrikson M. Cutaneous malignant melanoma in children and adolescents in Sweden, 1993-2002: The increasing trend is broken. Int J Cancer. 2007;121:323-8.
46. Hemminki K, Zhang H, Czene K. Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites. Int J Cancer. 2003;104:764-71.
47. Gaudette LA, Gao RN. Changing trends in melanoma incidence and mortality. Health Rep. 1998;10:29-41.
48. Lipsker D, Engel F, Cribier B, Velten M, Hedelin G. Trends in melanoma epidemiology suggest three different types of melanoma. Br J Dermatol. 2007;157:338-43.
49. Doherty VR, Brewster DH, Jensen S, Gorman D. Trends in skin cancer incidence by socioeconomic position in Scotland, 1978-2004. Br J Cancer. 2010;102:1661-4.
50. Streetly A, Markowe H. Changing trends in the epidemiology of malignant melanoma: Gender differences and their implications for public health. Int J Epidemiol. 1995;24:897-907.
51. Cayuela A, Rodríguez-Domínguez S, Vigil E, Conejo-Mir JS. Effect of age, birth cohort and period of death on skin melanoma mortality in Spain, 1975 through 2004. Int J Cancer. 2008;122:905-8.
52. Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: Evidence for contrasting trends between populations. Br J Cancer. 2000;82:1887-91.
53. Stang A, Valiukeviciene S, Aleknaviciene B, Kurtinaitis J. Time trends of incidence, mortality, and relative survival of invasive skin melanoma in Lithuania. Eur J Cancer. 2006;42:660-7.
54. Månsson-Brahme E, Johansson H, Larsson O, Rutqvist LE, Ringborg U. Trends in incidence of cutaneous malignant melanoma in a Swedish population 1976-1994. Acta Oncol. 2002;41:138-46.
55. Bleyen L, De Bacquer D, Myny K, Brochez L, Naeyaert JM, De Backer G. Trends in mortality from cutaneous malignant melanoma in Belgium. Int J Epidemiol. 1999;28:40-5.
56. Giles GG, Armstrong BK, Burton RC, Staples MP, Thursfield VJ. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. BMJ. 1996;312:1121-5.
57. Baade P, Coory M. Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control. Aust N Z J Public Health. 2005;29:383-6.
58. Mendes GL, Koifman RJ, Koifman S. Mortality frequency and trends attributed to melanoma in Brazil from 1980-2005. J Toxicol Environ Health A. 2010;73:850-7.
59. Stang A, Jöckel KH. Changing patterns of skin melanoma mortality in West Germany from 1968 through 1999. Ann Epidemiol. 2003;13:436-42.
60. Crocetti E, Carli P. Unexpected reduction of mortality rates from melanoma in males living in central Italy. Eur J Cancer. 2003;39:818-21.
61. Crocetti E, Carli P, Miccinesi G. Melanoma incidence in central Italy will go on increasing also in the near future: A registry-based, age-period-cohort analysis. Eur J Cancer Prev. 2007;16:50-4.
62. Zhou J, Enewold L, Zahm SH, Devesa SS, Anderson WF, Potter JF, McGlynn KA, Zhu K. Melanoma incidence rates among whites in the U.S. Military. Cancer Epidemiol Biomarkers Prev. 2011;20:318-23.
63. Klit A, Drejøe JB, Drzewiecki KT. Trends in the incidence of malignant melanoma in Denmark, 1978-2007. Incidence on the island of Bornholm compared with the whole country incidence in Denmark. Dan Med Bull. 2011;58:A4229.
64. Bosetti C, La Vecchia C, Naldi L, Lucchini F, Negri E, Levi F. Mortality from cutaneous malignant melanoma in Europe. Has the epidemic leveled off? Melanoma Res. 2004;14:301-9.
65. Balzi D, Carli P, Giannotti B, Paci E, Buiatti E. Cutaneous melanoma in the Florentine area, Italy: Incidence, survival and mortality between 1985 and 1994. Eur J Cancer Prev. 2003;12:43-8.
66. Insinga RP, Reither EN, Remington PL, Stephenson-Vine L. Trends in malignant melanoma incidence and mortality in Wisconsin, 1979-1997. WMJ. 2001;100:27-31.
2. Hall HI, Miller DR, Rogers JD, Bewerse B. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol. 1999;40:35-42.
3. MacKie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann Oncol.2009;20(Suppl.6):1-7.
4. Aceituno-Madera P, Buendía-Eisman A, Arias-Santiago S, Serrano-Ortega S. Changes in the incidence of skin cancer between 1978 and 2002. Actas Dermosifiliogr. 2010;101:39-46.
5. Montella A, Gavin A, Middleton R, Autier P, Boniol M. Cutaneous melanoma mortality starting to change: A study of trends in Northern Ireland. Eur J Cancer. 2009;45:2360-6.
6. Bulliard JL, Cox B. Cutaneous malignant melanoma in New Zealand: Trends by anatomical site, 1969-1993. Int J Epidemiol. 2000;29:416-23.
7. Héry C, Tryggvadóttir L, Sigurdsson T, Olafsdóttir E, Sigurgeirsson B, Jonasson JG, et al. A melanoma epidemic in Iceland: Possible influence of sunbed use. Am J Epidemiol. 2010;172:762-7.
8. Marcos-Gragera R, Vilar-Coromina N, Galceran J, Borràs J, Clèries R, Ribes J, et al. Rising trends in incidence of cutaneous malignant melanoma and their future projections in Catalonia, Spain: Increasing impact or future epidemic? J Eur Acad Dermatol Venereol. 2010;24:1083-8.
9. Registro Poblacional de Cáncer de Cali, Colombia. Melanoma, 1962-2007. Fecha de consulta: 11 de agosto de 2011. Disponible en: rpcc.univalle.edu.co.
10. Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA. 1989;262:2097-100.
11. Brochez L, Naeyaert JM. Understanding the trends in melanoma incidence and mortality: Where do we stand? Eur J Dermatol. 2000;10:71-5.
12. Lasithiotakis KG, Leiter U, Gorkievicz R, Eigentler T, Breuninger H, Metzler G, et al. The incidence and mortality of cutaneous melanoma in Southern Germany: Trends by anatomic site and pathologic characteristics, 1976 to 2003. Cancer. 2006;107:1331-9.
13. de Vries E, Bray FI, Eggermont AM, Coebergh JW; European Network of Cancer Registries. Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics. Eur J Cancer Prev. 2004;13:387-95.
14. Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol. 2009;27:3-9.
15. Metelitsa AI, Dover DC, Smylie M, de Gara CJ, Lauzon GJ. A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002). J Am Acad Dermatol. 2010;62:227-32.
16. Chellini E, Crocetti E, Carli P, Martini A, Giovannetti L. The melanoma epidemic debate: Some evidence for a real phenomenon from Tuscany, Italy. Melanoma Res. 2007;17:129-30.
17. Pellacani G, Lo Scocco G,Vinceti M,Albertini G, Raccagni AA, Baldassari L, et al .Melanoma epidemic across the millennium: Time trends of cutaneous melanoma in Emilia-Romagna (Italy) from 1997 to 2004. J Eur Acad Dermatol Venereol. 2008;22:213-8.
18. Marcoval J, Moreno A, Torras A, Baumann E, Graells J, Gallego MI. Changes in incidence of malignant melanoma in the last 19 years in a tertiary hospital on the Mediterranean coast. Actas Dermosifiliogr. 2008;99:464-8.
19. Cayuela A, Rodríguez-Domínguez S, Lapetra-Peralta J, ConejoMir JS. Has mortality from malignant melanoma stopped rising in Spain? Analysis of trends between 1975 and 2001. Br J Dermatol. 2005;152:997-1000.
20. Valentín SM, Sánchez JL, Figueroa LD, Nazario CM. Epidemiology of melanoma in Puerto Rico, 1987-2002. P R Health Sci J. 2007;26:343-8.
21. Whiteman DC, Bray CA, Siskind V, Green AC, Hole DJ, Mackie RM. Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion? Eur J Cancer Prev. 2008;17:243-50.
22. Coory M, Baade P, Aitken J, Smithers M, McLeod GR, Ring I. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control. 2006;17:21-7.
23. Buettner PG, MacLennan R. Geographical variation of incidence of cutaneous melanoma in Queensland. Aust J Rural Health. 2008;16:269-77.
24. Holterhues C, Vries E, Louwman MW, Koljenovi S, Nijsten T. Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005. J Invest Dermatol. 2010;130:1807-12.
25. Hallberg O. A theory and model to explain the skin melanoma epidemic. Melanoma Res. 2006;16:115-8.
26. Tryggvadóttir L, Gislum M, Hakulinen T, Klint A, Engholm G, Storm HH, et al. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964- 2003 followed up to the end of 2006. Acta Oncol. 2010;49:665-72.
27. Cicarma E, Juzeniene A, Porojnicu AC, Bruland ØS, Moan J. Latitude gradient for melanoma incidence by anatomic site and gender in Norway 1966-2007. J Photochem Photobiol B. 2010;101:174-8.
28. Pérez-Gómez B, Aragonés N, Gustavsson P, Lope V, López-Abente G, Pollán M. Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women. Br J Dermatol. 2008;158:766-72.
29. Stang A, Pukkala E, Sankila R, Söderman B, Hakulinen T. Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases. Int J Cancer. 2006;119:380-4.
30. Newnham A, Møller H. Trends in the incidence of cutaneous malignant melanomas in the south east of England, 1960-1998. J Public Health Med. 2002;24:268-75.
31. Bulliard JL, Cox B, Semenciw R. Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969-93. Cancer Causes Control. 1999;10:407-16.
32. de Vries E, Houterman S, Janssen-Heijnen ML, Nijsten T, van de Schans SA, Eggermont AM, et al. Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands. Ann Oncol. 2007;18:1110-6.
33. Shoo BA, Kashani-Sabet M. Melanoma arising in African-, Asian-, Latino- and Native-American populations. Semin Cutan Med Surg. 2009;28:96-102.
34. Ulmer MJ, Tonita JM, Hull PR. Trends in invasive cutaneous melanoma in Saskatchewan 1970-1999. J Cutan Med Surg. 2003;7:433-42.
35. Downing A, Newton-Bishop JA, Forman D. Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003. Br J Cancer. 2006;95:91-5.
36. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. J Invest Dermatol. 2009;129:1666-74.
37. Levi F, Te VC, Randimbison L, La Vecchia C. Trends in incidence of various morphologies of malignant melanoma in Vaud and Neuchatel, Switzerland. Melanoma Res. 2005;15:73-5.
38. Rouhani P, Hu S, Kirsner RS. Melanoma in Hispanic and black Americans. Cancer Control. 2008;15:248-53.
39. Rouhani P, Pinheiro PS, Sherman R, Arheart K, Fleming LE, Mackinnon J, et al. Increasing rates of melanoma among nonwhites in Florida compared with the United States. Arch Dermatol. 2010;146:741-6.
40. Hu S, Parmet Y, Allen G, Parker DF, Ma F, Rouhani P, Kirsner RS. Disparity in melanoma: A trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida. Arch Dermatol. 2009;145:1369-74.
41. Bellows CF, Belafsky P, Fortgang IS, Beech DJ. Melanoma in African-Americans: Trends in biological behavior and clinical characteristics over two decades. J Surg Oncol. 2001;78:10-6.
42. Bradford PT, Anderson WF, Purdue MP, Goldstein AM, Tucker MA. Rising melanoma incidence rates of the trunk among younger women in the United States. Cancer Epidemiol Biomarkers Prev. 2010;19:2401-6.
43. Dal H, Boldemann C, Lindelöf B. Does relative melanoma distribution by body site 1960-2004 reflect changes in intermittent exposure and intentional tanning in the Swedish population? Eur J Dermatol. 2007;17:428-34.
44. Nieto A, Ruiz-Ramos M, Abdel-Kader L, Conde M, Camacho F. Gender differences in rising trends in cutaneous malignant melanoma in Spain, 1975-98. Br J Dermatol. 2003;148:110-6.
45. Karlsson PM, Fredrikson M. Cutaneous malignant melanoma in children and adolescents in Sweden, 1993-2002: The increasing trend is broken. Int J Cancer. 2007;121:323-8.
46. Hemminki K, Zhang H, Czene K. Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites. Int J Cancer. 2003;104:764-71.
47. Gaudette LA, Gao RN. Changing trends in melanoma incidence and mortality. Health Rep. 1998;10:29-41.
48. Lipsker D, Engel F, Cribier B, Velten M, Hedelin G. Trends in melanoma epidemiology suggest three different types of melanoma. Br J Dermatol. 2007;157:338-43.
49. Doherty VR, Brewster DH, Jensen S, Gorman D. Trends in skin cancer incidence by socioeconomic position in Scotland, 1978-2004. Br J Cancer. 2010;102:1661-4.
50. Streetly A, Markowe H. Changing trends in the epidemiology of malignant melanoma: Gender differences and their implications for public health. Int J Epidemiol. 1995;24:897-907.
51. Cayuela A, Rodríguez-Domínguez S, Vigil E, Conejo-Mir JS. Effect of age, birth cohort and period of death on skin melanoma mortality in Spain, 1975 through 2004. Int J Cancer. 2008;122:905-8.
52. Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: Evidence for contrasting trends between populations. Br J Cancer. 2000;82:1887-91.
53. Stang A, Valiukeviciene S, Aleknaviciene B, Kurtinaitis J. Time trends of incidence, mortality, and relative survival of invasive skin melanoma in Lithuania. Eur J Cancer. 2006;42:660-7.
54. Månsson-Brahme E, Johansson H, Larsson O, Rutqvist LE, Ringborg U. Trends in incidence of cutaneous malignant melanoma in a Swedish population 1976-1994. Acta Oncol. 2002;41:138-46.
55. Bleyen L, De Bacquer D, Myny K, Brochez L, Naeyaert JM, De Backer G. Trends in mortality from cutaneous malignant melanoma in Belgium. Int J Epidemiol. 1999;28:40-5.
56. Giles GG, Armstrong BK, Burton RC, Staples MP, Thursfield VJ. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. BMJ. 1996;312:1121-5.
57. Baade P, Coory M. Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control. Aust N Z J Public Health. 2005;29:383-6.
58. Mendes GL, Koifman RJ, Koifman S. Mortality frequency and trends attributed to melanoma in Brazil from 1980-2005. J Toxicol Environ Health A. 2010;73:850-7.
59. Stang A, Jöckel KH. Changing patterns of skin melanoma mortality in West Germany from 1968 through 1999. Ann Epidemiol. 2003;13:436-42.
60. Crocetti E, Carli P. Unexpected reduction of mortality rates from melanoma in males living in central Italy. Eur J Cancer. 2003;39:818-21.
61. Crocetti E, Carli P, Miccinesi G. Melanoma incidence in central Italy will go on increasing also in the near future: A registry-based, age-period-cohort analysis. Eur J Cancer Prev. 2007;16:50-4.
62. Zhou J, Enewold L, Zahm SH, Devesa SS, Anderson WF, Potter JF, McGlynn KA, Zhu K. Melanoma incidence rates among whites in the U.S. Military. Cancer Epidemiol Biomarkers Prev. 2011;20:318-23.
63. Klit A, Drejøe JB, Drzewiecki KT. Trends in the incidence of malignant melanoma in Denmark, 1978-2007. Incidence on the island of Bornholm compared with the whole country incidence in Denmark. Dan Med Bull. 2011;58:A4229.
64. Bosetti C, La Vecchia C, Naldi L, Lucchini F, Negri E, Levi F. Mortality from cutaneous malignant melanoma in Europe. Has the epidemic leveled off? Melanoma Res. 2004;14:301-9.
65. Balzi D, Carli P, Giannotti B, Paci E, Buiatti E. Cutaneous melanoma in the Florentine area, Italy: Incidence, survival and mortality between 1985 and 1994. Eur J Cancer Prev. 2003;12:43-8.
66. Insinga RP, Reither EN, Remington PL, Stephenson-Vine L. Trends in malignant melanoma incidence and mortality in Wisconsin, 1979-1997. WMJ. 2001;100:27-31.
Cómo citar
1.
Oliveros C, Bravo JC, Zambrano Ángela, Cepeda M, Ramírez AF. Tendencia de la incidencia y la mortalidad en melanoma maligno en los últimos 60 años y análisis de los datos del Registro Poblacional (sic.) de Cáncer de Cali. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 1 de julio de 2012 [citado 16 de abril de 2024];20(3):255-6. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/236
Descargas
Los datos de descargas todavía no están disponibles.
Descargas
Publicado
2012-07-01
Cómo citar
1.
Oliveros C, Bravo JC, Zambrano Ángela, Cepeda M, Ramírez AF. Tendencia de la incidencia y la mortalidad en melanoma maligno en los últimos 60 años y análisis de los datos del Registro Poblacional (sic.) de Cáncer de Cali. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 1 de julio de 2012 [citado 16 de abril de 2024];20(3):255-6. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/236
Número
Sección
Artículo de revisión
